Membranous Nephropathy: From Research Bench to Personalized Care
Membranous nephropathy is a glomerulopathy that causes nephrotic syndrome and, in at least a third of cases, lasting end-stage kidney disease (ESKD). It is also a rare case of revolutionary changes in our understanding of the disease, that translates from scientific findings to real diagnosis and tr...
Main Authors: | Barbara Moszczuk, Krzysztof Kiryluk, Leszek Pączek, Krzysztof Mucha |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/6/1205 |
Similar Items
-
Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy
by: Anne-Els van de Logt, et al.
Published: (2021-06-01) -
Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy
by: Maxime Teisseyre, et al.
Published: (2020-05-01) -
Primary membranous glomerulonephritis with negative serum PLA2R in haemophilia A successfully managed with rituximab – case report and review of the literature
by: Nicholas Meyer, et al.
Published: (2021-07-01) -
Immune-Monitoring Disease Activity in Primary Membranous Nephropathy
by: Paolo Cravedi, et al.
Published: (2019-11-01) -
Distribution of circulating and glomerular IgG subclasses against full-length anti-phospholipase A2 receptor and its epitopes in primary membranous nephropathy
by: Li, Lee Chuan
Published: (2016)